Cargando…
Regional citrate anticoagulation for continuous renal replacement therapy in newborns
BACKGROUND: Regional citrate anticoagulant (RCA) is recommended as the preferred anticoagulant regimen for continuous renal replacement therapy (CRRT) in adults; however, it is rarely reported in neonates due to concerns associated with their immature liver. Few studies have reported on the use of R...
Autores principales: | Huang, Haixia, Deng, Xing, Bai, Ke, Liu, Chengjun, Xu, Feng, Dang, Hongxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030704/ https://www.ncbi.nlm.nih.gov/pubmed/36969287 http://dx.doi.org/10.3389/fped.2023.1089849 |
Ejemplares similares
-
Novel blood product transfusion regimen to prevent clotting and citrate accumulation during continuous renal replacement therapy with regional citrate anticoagulation in children
por: Sun, Yuelin, et al.
Publicado: (2023) -
Clinical application of regional citrate anticoagulation for continuous renal replacement therapy in children with liver injury
por: Hu, Fang, et al.
Publicado: (2022) -
Regional citrate anticoagulation with a substitute containing calcium for continuous hemofiltration in children
por: Bai, Ke, et al.
Publicado: (2019) -
Clinical application of regional citrate anticoagulation for membrane-based therapeutic plasma exchange in children with liver failure
por: Hu, Jun, et al.
Publicado: (2023) -
Citrate anticoagulation for continuous renal replacement therapy in small children
por: Soltysiak, Jolanta, et al.
Publicado: (2013)